Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.17
Delayed Data
As of Feb 24
 +0.0168 / +0.78%
Today’s Change
2.05
Today|||52-Week Range
4.80
-5.79%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.15
Today’s open2.16
Day’s range2.13 - 2.19
Volume53,556
Average volume (3 months)75,431
Market cap$23.9M
Dividend yield--
Data as of 3:53pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+47.37%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.67%
P/E ratioNM
Price/Sales1.80
Price/Book0.44

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...-0.02-2.40%
APRIApricus Biosciences ...-0.01-0.38%
ABIOARCA Biopharma Inc+0.03+0.98%
CLRBCellectar Bioscience...-0.06-2.73%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$21.0M
Annual profit (last year)-$9.2M
Net profit margin-44.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs